Quinsair (levofloxacin)

pCPA File Number: 20963

Negotiation Status:

Concluded with an LOI

Indication(s):

Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections

Sponsor/Manufacturer:

Raptor Pharmaceuticals Inc.

CDA-AMC Project Number:

SR0493-000

pCPA Engagement Letter Issued:

2017-05-29

Negotiation Process Concluded:

2018-10-11